Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11970502 Macrocyclic antiviral agents

Patent 11970502 was granted and assigned to Enanta Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

0

Current Assignee

Enanta Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yat Sun Or0

Jiajun Zhang0

Xiaowen Peng0

Date of Patent

April 30, 2024

0

Patent Application Number

177352030

Date Filed

May 3, 2022

0

Patent Citations

US Patent 9290757 Protease screening methods and proteases identified thereby

0

US Patent 8222288 Small molecule inhibitors of MDM2 and the uses thereof

0

US Patent 8222425 Organic compounds and their uses

0

US Patent 8372802 Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

0

US Patent 11058779 Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

0

US Patent 11124497 Inhibitors of cysteine proteases and methods of use thereof

0

US Patent 11174231 Inhibitors of cysteine proteases and methods of use thereof

0

US Patent 11207370 Peptidomimetics for the treatment of coronavirus and picornavirus infections

0

...

Patent Primary Examiner

Jeffrey H Murray

0

CPC Code

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11970502 Macrocyclic antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool